1. Introduction {#s0005}
===============

Traditional Chinese medicine (TCM), especially herbal medicine, is gaining increasing attention worldwide for its millennia-old practices and its potential all-natural therapeutic applications. Huangqin Tang (HQT), a well-known Chinese medicine formula, is a combination of four herbal medicines 3:2:2:2 by weight, namely Radix Scutellariae (*Scutellaria baicalensis* Georgi), Radix Paeoniae Alba (*Paeonia lactiflora* Pall.), Radix et Rhizoma Glycyrrhizae (*Glycyrrhiza uralensis* Fisch., *Glycyrrhiza inflata* Bat. or *Glycyrrhiza glabra* L.) and Fructus Jujubae (*Ziziphus jujuba* Mill). HQT has traditionally been used for the treatment of colds and gastrointestinal diseases with symptoms of fever, abdominalgia and diarrhea[@bib1], [@bib2]. Recently, some studies have reported that PHY906, an extract derived from HQT, reduces gastrointestinal toxicity and enhances the anti-tumor effect of some anti-cancer drugs[@bib3], [@bib4]. This extract has been studied in five clinical trials with patients suffering from different types of cancer in both the US and Taiwan with very encouraging results. Radix Scutellariae, the chief ingredient of HQT, has been widely used in TCM prescriptions[@bib5]. It is known to be effective in the treatment of fever, inflammation, cancers and other gastrointestinal diseases[@bib6], [@bib7], [@bib8], [@bib9]. The major functional constituents of Radix Scutellariae are flavonoid glycosides (*e.g*., baicalin, wogonoside and oroxylin-A-glucoside) and flavonoids (*e.g*., baicalein, wogonin and oroxylin-A)[@bib10], [@bib11], [@bib12]. Phytochemical studies have shown that the main constituents of the other three herbs (Radix Paeoniae Alba, Radix et Rhizoma Glycyrrhizae and Fructus Jujubae) are flavones, isoflavones, terpenoids, volatile oils and polysaccharides with a wide range of pharmacological properties[@bib13], [@bib14], [@bib15], such as anti-inflammatory, analgesic, antitussive, tumor suppressor and immunomodulatory[@bib16], [@bib17], [@bib18], [@bib19]. Flavonoids are the important effective components from HQT.

Generally, the chemical composition of herbal formulations may vary greatly due to differences in plant origins, cultivation areas and practices, climate conditions and processing protocols among others[@bib20], [@bib21], [@bib22]. This leads to wide disparities in quality among different samples. An effective and feasible method should take the complexity and variability of the chemical constituents of herbal medicines into consideration simultaneously. However, previous studies addressing HQT using fingerprinting analysis failed to include enough quality control markers or had a limited study sample population[@bib23], [@bib24]. Here we use a combinatorial approach with chromatographic fingerprinting analysis, a multiple-component quantitative analysis and animal pharmacology to comprehensively assess the quality of different HQT samples.

2. Materials and methods {#s0010}
========================

2.1. Chemicals and herbal materials {#s0015}
-----------------------------------

The reference standards for baicalin, wogonoside, oroxylin-A-glucoside, baicalein, wogonin, oroxylin-A, liquiritin, liquiritigenin, isoliquiritoside, isoliquiritigenin, liquiritin apioside and isoliquiritin apioside were purchased from Zelang Pharmaceuticals (Nanjing, China). The purity of these compounds was higher than 98% by HPLC analysis based on a peak area normalization method. Aspirin (Scientific Research Special) and carrageenin (Sigma Life Science), both in pure powdered form, were also used. Analytical-grade ethanol and acetic acid were purchased from Beijing Chemical Factory (Beijing, China). HPLC-grade methanol and acetonitrile were obtained from Fisher (Fisher Scientific, USA). Purified water was purchased from Wahaha Group (Hangzhou, China).

Crude Radix Scutellariae from three origins that met the requirements of Beijing Food and Drug Administration was collected from different pharmacies in Beijing. Crude Radix Rhizoma Glycyrrhizae, Radix Paeoniae and Fructus Jujubae (Herbal Pieces Co., Ltd.; originally from Anhui, Neimeng and Hebei, respectively) were collected from Beijing Wukesong Clinic. The source and labeling of the medicines is summarized in [Table 1](#t0005){ref-type="table"}. All herbal medicines were identified by Professor Xianduan Li of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and voucher specimens were deposited in the institute. HPLC analysis was used to confirm that the content of baicalin in crude Radix Scutellariaeis is 14.9±2.7% in accordance with the quality level request of 4.0% established in the *Chinese Pharmacopoeia* 2010[@bib5].

2.2. Preparation of HQT granule, HQT sample solutions and standard solutions {#s0020}
----------------------------------------------------------------------------

Ten batches of crude Radix Scutellariae (9 g) and one batch of Radix et Rhizoma Glycyrrhizae (6 g), Radix Paeoniae (6 g) and Fructus Jujubae (6 g) were weighed and thoroughly soaked in water for 30 min. For the first decoction, 10-fold water (1:10 *w/v*) was added to the crude drugs and the mixture was boiled for 1.5 h, after which the decoction was filtered. At this point, 8-fold water (1:8 *w/v*) was added to the crude drug residue. Then the mixture was boiled for additional 1 h. Following filtration, the decoction was combined with previous one and the sample was dried in a vacuum oven at 60 °C into a granulated powder which was packaged and stored at 4 °C for future use. Ratio extraction was calculated using the following formula:$${Ratio}{extraction}{\ \left( \% \right)} = W_{1}/W_{2} \times 100$$where *W*~1~ is the weight of the dried HQT granules and *W*~2~ is the weight of the crude HQT mixture.

Dried HQT granules (approximately 0.50 g) were ground into a powder (approximately 40 meshes) and weighed. For phytochemical analysis, the HQT powder was extracted with 50 mL of 75% (*w/v*) ethanol in a water bath at 80 °C for 30 min with one shaking every 15 min. After adjusting to ambient temperature, ethanol was then added to compensate for the lost weight during the extraction. Finally, the supernatant was filtered through a 0.22 µm membrane filter and injected into the HPLC and LC--MS system for analysis. For animal experiments, the HQT powder was dissolved in water at a temperature of 80 °C and shaken to a final nominal concentration of 0.5 mg dry weight HQT powder extract per mL of water.

The following standard stock solutions were prepared in methanol, stored at 4 °C, and diluted as required for their use in the calibration curves: baicalin (2074.00 mg/L), wogonoside (1200.00 mg/L), oroxylin-A-glucoside (750.00 mg/L), baicalein (270.00 mg/L), wogonin (72.00 mg/L), oroxylin-A (27.20 mg/L), liquiritin (299.00 mg/L), liquiritigenin (129.00 mg/L), isoliquiritoside (6.29 mg/L), isoliquiritigenin (6.43 mg/L), liquiritin apioside (24.90 mg/L) and isoliquiritin apioside (2.94 mg/L).

2.3. HPLC and LC--MS analysis {#s0025}
-----------------------------

HPLC analysis was performed on a Shimadzu LC-20A system (Kyoto, Japan) equipped with an SPD-20A photodiode array detector. The analytes were separated on a Dikma Diamonsil C18 column (250 mm×4.6 mm, 5 μm). The mobile phase consisted of A (acetonitrile) and B (water containing 1% acetic acid). The linear gradient conditions were optimized as follows: 0--13 min, 17% A; 13--15 min, 17%--20% A; 15--50 min, 20%--30% A; 50--62 min, 30%--40% A; 62--70 min, 40%--44% A; 70--80 min, 44%--100% A. The flow rate was 1.0 mL/min at 35 °C. UV absorbance was monitored at 276 nm for fingerprinting analysis and 276 nm and 370 nm simultaneously for the quantitative analysis.

LC--MS^*n*^ analysis was performed on an Aglient Ion Trap6320 mass spectrometer system with an electrospray ion source (ESI) (Applied Biosystems, Toronto, Canada). The LC conditions used for LC--MS^*n*^ analysis were the same as those used for the HPLC analysis described above. The optimized MS conditions were fixed as follows: positive ions and negative ions mode was applied. The gas system was set as follows: nebulizer (N~2~), 42 psi; dry gas (N~2~), 12 L/min; dry temp., 350 °C. Helium was used as collision gas (compound stability: 100%; trap level: 100%; scan range: 100--1500 Da). The injection volume was 10 µL and all solutions were filtered through a syringe filter (0.22 µm) before analysis.

2.4. Method validation {#s0030}
----------------------

HPLC fingerprinting analysis was developed and its precision, stability and repeatability were validated according to the established guidelines of the China Food and Drug Administration (CFDA) of China[@bib25]. Precision was determined by analyzing the five replicates of a sample of an HQT-S1 solution on the same day. To confirm the repeatability of results, five different sample solutions prepared from the same sample (HQT-S5) were analyzed. Five injections of the same sample HQT-S1 solution at different time points (0, 3, 6, 9 and 12 h) were analyzed to evaluate sample stability. The correlation coefficients between the reference HPLC fingerprints and the sample HPLC fingerprints were calculated as a measure of precision, repeatability and stability.

For quantitative analysis, linearity, lower limit of detection (LLOD) and lower limit of quantification (LLOQ), precision (inter-day and intra-day precision), repeatability, stability, accuracy and specificity were measured and validated according to the guidelines of the International Conference on Harmonization (ICH)[@bib26]. Standard stock solutions containing 11 analytes were prepared and diluted with methanol to the appropriate concentrations to be used in the calibration curves to evaluate LLOD and LLOQ. Calibration curves were generated by plotting peak area against the concentrations of each analyte. The LLOD and LLOQ of the 11 compounds investigated were defined as the amount for which the signal-to-noise ratio (*S/N*) was 3 and 10, respectively. The intra-day and inter-day precisions of the method were assessed by performing 6 replicate injections of a mixed standard solution in day 1 and once daily after that for three consecutive days, respectively. The reproducibility of this method was determined by analyzing 6 independently prepared sample solutions (HQT-S10). The stability was evaluated by repeated analysis of the same sample solution (HQT-S1) every 3 h for a 12 h time period at room temperature. Recovery tests were carried out to determine the accuracy of the method by adding a known amount of the corresponding marker compound to the known sample (HQT-S5). Specificity tests were investigated by using UV spectra and MS fragmentation. The samples were extracted and analyzed as described above. The average percent recoveries were evaluated by calculating the ratio of detected amount *versus* the added amount.

2.5. Pharmacological studies {#s0035}
----------------------------

Adult male Wistar rats (190--210 g) were purchased from the Institute of Experimental Animals (Academy of Military Medical Science; Beijing, China), housed under standard conditions (25±5 °C, 40%--70% relative humidity, 12 h/12 h light--dark cycle) and fed the standard diet and water ad libitum. Antipyretic and anti-inflammatory activities were evaluated based on the rat pyrexia models[@bib27] and carrageenin-induced rat hind paws oedema, respectively. Specifically, 1% carrageenin suspension in 0.9% NaCl was injected into the plantar surfaces of the 2 hind paws (0.1 mL/hind paw). Following injection, the volume of the right paw was measured using a YLS-7B Toe Volume Measuring Instrument (Jinan, China). The rectal temperature was measured 3 times daily (at 9:00, 15:00 and 21:00) using a Digital Electronic Thermometer (Shenzhen, China) for 3 days, and only animals with no more than 0.3 °C fluctuations in body temperature were used in the experiments. Sixty rats were randomly assigned into 6 groups of 10 rats each. The following experimental conditions were used. Control group: treated with water; reference group: treated with aspirin (100 mg/kg body weight) dissolved in water, HQT groups: treated with either extract of HQT-S3, HQT-S4, HQT-S6 or HQT-S8 (7.0 g/kg body weight) dissolved in water. In this study, water, aspirin and HQT dosages of 1.4 mL/kg body weight were administrated orally once a day for 3 consecutive days. The last treatment was on day 3, 1 h after the carrageen injection. Response values were recorded at 0, 1, 2, 3, 4, 6 and 8 h as described above. Changes in rectal temperature and paw volume were calculated using the following formula: change in rectal *T* (°C)=*T*~*t* ~-- *T*~0 h~; Changes in paw volume (mL)=(*V*~*t*~ -- *V*~0 h~), where *T*~*t*~ is the rectal temperature at different time points and *V*~*t*~ is the volume of the right paw at different time points. All the rat studies were performed in accordance with the protocols established by the Animal Care and Use Committee of the China Academy of Chinese Medical Sciences.

2.6. Data analysis {#s0040}
------------------

Fingerprinting analysis and quantitative determinations were performed in triplicate. Similarity analysis was performed using the Similarity Evaluation System for Chromatographic Fingerprint of TCM software as established by the Chinese Pharmacopoeia Committee (Version 2008 A). The correlation coefficients of the chromatographic profiles of the samples were calculated and the reference fingerprint chromatogram was calculated and generated.

Principal component analysis (PCA) was used to sort samples into groups[@bib28] using Simca-P11.0 (Umetrics, Umea, Sweden) to differentiate and classify the 10 HQT samples based on the principal peaks. One HQT sample from one group was chosen and evaluated through the proposed pharmacological method. The comparison of mean pharmacodynamic values was done using the Student *t*-test. A *P*-value less than 0.05 was considered significant.

3. Results {#s0045}
==========

3.1. Fingerprinting analysis of HQT {#s0050}
-----------------------------------

### 3.1.1. Method validation {#s0055}

In order to confirm the accuracy of the equipment, we analyzed 5 successive injections of a sample solution and calculated the correlation coefficients between the reference HPLC fingerprint and the sample HPLC fingerprints. The values obtained were 0.998, indicating that the accuracy of our measurements was satisfactory. Five injections of the same sample solution at different time points (0, 3, 6, 9 and 12 h) were analyzed and the correlation coefficients were calculated to determine whether the sample solutions were stable during the measurement period. The values obtained 0.961 (0 h), 0.961 (3 h), 0.961 (6 h), 0.963 (9 h) and 0.962 (12 h) confirmed that the sample solutions were stable during the measurement periods. At this point, 5 solutions from the same sample were prepared using the same method and were injected individually. The correlation coefficients were 0.999 (0 h), 0.999 (3 h), 0.999 (6 h), 0.999 (9 h), and 0.998 (12 h) demonstrating the repeatability of the analytical method.

### 3.1.2. Sample analysis {#s0060}

Using the parameters described above, we analyzed the 10 batches of HQT samples. The HPLC fingerprinting profiles are shown in [Fig. 1](#f0005){ref-type="fig"}. We found 26 common peaks (area greater than 0.5% per chromatogram and common to all chromatograms). [Table 1](#t0005){ref-type="table"} shows that the similarity between the values obtained for the 10 samples was higher than 0.997, except for HQT-S3 for which the similarity value was 0.990. This indicates a high consistency and stability between the batches of HQT tested.

3.2. Identification of the common peaks {#s0065}
---------------------------------------

### 3.2.1. Herbal source identification {#s0070}

The decoction of HQT and its ingredient herbs (namely Radix Scutellariae, Radix et Rhizoma Glycyrrhizae, Radix Paeoniae Alba and Fructus Jujubae) at the concentrations tested were simultaneously analyzed using the chromatographic fingerprinting analysis method. Peaks were assigned to each herb by comparing to the retention time of the peaks in the chromatograms of the individual herbal ingredients. As shown in [Fig. 2](#f0010){ref-type="fig"}, 26 peaks in the HQT HPLC fingerprint were unique to an individual herbal component. Specifically, we found the following number of unique peaks: 22 peaks for Radix Scutellariae, 3 peaks for Radix et Rhizoma Glycyrrhizae, 1 peak for Radix Scutellariae and Radix et Rhizoma Glycyrrhizae. These peaks represented 90% of the total area of the chromatogram from 0 to 80 min at a threshold of 0.5%. Small peaks in the HQT HPLC fingerprint were ascribed to Radix Paeoniae and Fructus Jujubae.

### 3.2.2. Compounds identification {#s0075}

As shown in [Fig. 3](#f0015){ref-type="fig"} and [Table 2](#t0010){ref-type="table"}, 11 peaks in the HQT HPLC fingerprints (8 peaks in spectra at 276 nm and 3 peaks in spectra at 370 nm) were identified and confirmed using the reference compounds available. An additional 9 peaks were tentatively identified using their UV spectra and MS--MS fragmentation characteristics. The peaks marked with 3, 10, 11, 15, 18, 22, 24 and 26 were liquiritin, baicalin, liquiritigenin, oroxylin-A-glucoside, wogonoside, baicalein, wogonin and oroxylin-A respectively. The peaks marked with 8', 9' and 22' were isoliquiritin apioside, isoliquiritoside and isoliquiritigenin, respectively, which were more readily detected at 370 nm. A list of these identified peaks is provided in [Supplementary Fig. 1](#s0135){ref-type="sec"} and [Table 1](#t0005){ref-type="table"}. No novel compounds were identified. Peak 2 contains liquiritin apioside, a finding that needs to be confirmed in future studies. The 11 confirmed compounds were chosen as markers for quantitative analysis in ten batches of HQT samples.

3.3. Quantitative analysis of HQT {#s0080}
---------------------------------

### 3.3.1. Method validation {#s0085}

All of the peaks in the HPLC profiles obtained from the HQT batches analyzed contained one compound except for peak 2, proving the accuracy of our analysis. However, Peak 3 was only roughly quantified due to limited peak resolution. A detailed description of the calibration curve parameters, precision, reproducibility, stability and recovery is presented in [Table 3](#t0015){ref-type="table"}. Good linearity (*R*\>0.999) was achieved within the investigated ranges for all the analytes tested. The LLOD of the 11 analytes was within the range of 0.034--0.188 mg/L and LLOQ was within the range of 0.068--0.750 mg/L. The results of intra-day and inter-day precisions, their reproducibility and stability showed that the relative standard deviation (RSD) values were all less than 4.0%. The recovery of the method was in the range of 90%--101%, with an RSD less than 4.0% for all analytes. The validation results indicated that the system and the HPLC method were excellent for simultaneous quantitative evaluation of 11 flavonoids in HQT.

### 3.3.2. Sample analysis {#s0090}

The analytical method we developed was successfully applied for the simultaneous determination of 11 compounds in 10 batches of HQT obtained from different sources. [Table 4](#t0020){ref-type="table"} shows the mean content of each sample, which was analyzed in triplicate and calculated using the external standard method. The distribution of the 11 compounds was very similar among the HQT batches tested. Baicalin was the most common component and isoliquiritigenin was the least common in the batches tested. The relative quantities of the individual components varied with the RSD value. For example, the content of baicalin was in the range of 5.33%--11.10%, with an RSD value of 18.98%. Although Radix et Rhizoma Glycyrrhizae is from the same batch, flavonoids of Radix et Rhizoma Glycyrrhizae showed different distributions in HQT (RSD value, 6.5%--28.0%). The RSD of the total amount of the 11 components was 13.49±2.13%. HQT-S4 contained the greatest abundance of the 11 components identified, specifically baicalin and wogonoside. HQT-S3 contained the lowest abundance, which partly explained the low similarity with the other batches tested. Among the 11 flavonoids identified, baicalin and wogonoside contributed more than 84% of the total composition.

### 3.3.3. PCA analysis for the HQT batches {#s0095}

PCA was performed to distinguish the studied samples using the 11 quantified components identified. The score plots derived from the PCA are shown in [Fig. 4](#f0020){ref-type="fig"}. For the following study of animal pharmacodynamic evaluation, the 10 samples could be manually divided into 4 domains based on the score plots. The first domain was HQT-S3 and HQT-S5, and the second one was HQT-S4, which is far from the other samples. The third domain was HQT-S1, -S6, -S9 and -S10. The last domain was HQT-S2, -S7 and -S8, which were close to each other.

3.4. Anti-inflammatory and antipyretic activity of HQT {#s0100}
------------------------------------------------------

HQT demonstrated markedly anti-inflammatory, antipyretic, and analgesic efficacy in previous study[@bib1]. Herein, HQT-S3, -S4, -S6 and -S8 were selected for a comparative study of their antipyretic and anti-inflammatory activities. HQT was well-tolerated overall and had no apparent toxic effects. As shown in [Fig. 5](#f0025){ref-type="fig"}, HQT-S3, -S4 and -S6 showed statistically significant decreases in fever while HQT-S3, -S4, -S6 and -S8 showed statistically significant decreases in paw edema, compared with the control rats. This study indicates that HQT from different batches has significant antipyretic (all except HQT-S8) and anti-inflammatory effects (*P*\<0.05). No significant differences were observed between the different batches of HQT except for the antipyretic effect of HQT-S3 and HQT-S4 at 6 h and the anti-inflammatory effect of HQT-S4, HQT-S6 and HQT-S8. For example, the changes in rectal temperature were 0.64±0.46, 0.80±0.42, 0.61±0.22 and 0.89±0.50 °C and the changes in paw volume were 0.08±0.05, 0.06±0.06, 0.08±0.06 and 0.10±0.06 mL for HQT-S3, -S4, -S6 and -S8, respectively, at 3 h after the last administration of HQT. These *in vivo* results were consistent with the similarities in the chemical fingerprints between these batches.

4. Discussion {#s0105}
=============

4.1. Optimization of HPLC conditions and extraction methods {#s0110}
-----------------------------------------------------------

Here we investigated the following HPLC conditions: mobile phase, column, detection wavelength and elution program for the optimization of chromatographic conditions. Two different types of LC columns were investigated: Aglient Zorbax SB-C18 (250 mm×4.6 mm, 5 μm) and Dikma Diamonsil C18 (2) (250 mm×4.6 mm, 5 μm). The Dikma Diamonsil C18 (2) column was suitable for analysis because it provided better separation efficiency. The HPLC mobile phase in methanol--water, acetonitrile--water and the different concentrations of modifiers (formic acid and acetic acid) were investigated. Finally, acetonitrile--water containing 1% *v*/*v* acetic acid was applied for the separation of chemical constituents in HQT. The UV detector was employed because of the flavonoid spectra in Radix Scutellariae and Radix et Rhizoma Glycyrrhizae. The monitoring wavelength was set at 276 nm for fingerprinting analysis, whereas 276 nm and 370 nm were simultaneously used for quantitative analysis. Various extraction methods (ultrasonic extraction, cold-dipping under ambient temperature, hot-dipping in an 80 °C water bath), solvents (water, methanol and ethanol at different concentrations), and time were evaluated to obtain the optimized extraction efficiency. According to the total content of the 12 flavonoids, the highest extraction efficiency was obtained with hot-dipping at 75% (*v*/*v*) ethanol for 30 min in an 80 °C water bath.

4.2. Quality control {#s0115}
--------------------

Bioactive, characteristic, main, synergistic, correlative, toxic and general components are often used as quality control markers of single medicinal herbs[@bib29]. The chemical marker is useful for those herbal medicines of limited and known chemical composition. In addition to the method specified in the *Chinese Pharmacopoeia*, there are many studies on the quality control of Radix Scutellariae, Radix Paeoniae, Radix et Rhizoma and Glycyrrhizaeand Fructus Jujubae[@bib30], [@bib31], [@bib32], [@bib33]. In this study, the crude Radix Scutellariae, Radix Paeoniae, Radix et Rhizoma Glycyrrhizae and Fructus Jujubae were collected from their authentic regions, identified by a senior pharmacist according to the requirements of the Beijing Food and Drug Administration. In addition, the content of baicalin in crude Radix Scutellariae was analyzed by HPLC according to the directions of the *Chinese Pharmacopoeia*. However, it is more challenging to ascertain the quality for TCM prescriptions of HQT than for the single medicinal herbs. Unexpected differences were to be found in the compatibility application of the ingredients of HQT after a series of pharmaceutical processing, such as decocting, boiling, concentrating and drying. Chromatographic fingerprinting is a rational and powerful approach to characterize a multi-herb formulation with a complicated chemical profile, and HPLC has proven to be a stable, economical and reliable method for fingerprinting analysis. In this study, 10 batches of crude Radix Scutellariae collected from three different regions and processed according to a standard protocol were analyzed by the HPLC fingerprinting method. Similarity analysis demonstrated that the 10 batches of HQT were homogeneous. Twenty-six common peaks were detected and 11 components were quantified in the chemical profile of HQT. The most common components were the flavonoids from Radix Scutellariae and Radix et Rhizoma Glycyrrhizae (15% of the weight). The distribution of the 11 biologically active components was similar between the different batches. Moreover, our previous studies have shown that 25 (except peak marked 23) of the 26 common peaks in HQT HPLC profiles could enter the body through the intestine and liver in a perfused intestine--liver preparation and most of them demonstrate good pharmacokinetic properties in rats[@bib34], [@bib35]. These compounds have applications in the treatment of inflammation, cancer and gastrointestinal disorders. Therefore, HPLC fingerprinting together with simultaneous quantification of the identified flavonoids could be taken into the consideration for quality control of HQT.

Nevertheless, there are still many components that could not be detected due to the limitations of our analysis method. For example, no components were identified for Radix Paeoniae Alba and Fructus Jujubae. Furthermore, the absolutely accurate contents of single or limited constituents maybe not so crucial for the quality control of herbal medicines. There have been some reports about the quality control method using the combination of the chemical profiling and pharmacodynamic measurements[@bib24], [@bib36]. In order to provide a complete picture of the composition of HQT, a pharmacological evaluation model was used for full quality assurance. Since an herbal medicine has diverse therapeutic applications, accurate, sensitive and accessible efficacy indicators are critical and necessary for their pharmacological evaluation. HQT possesses a wide range of pharmacological properties such as anti-inflammatory, antipyretic, and analgesic, but in this study we chose not to focus on the latter. Since both fever and paw edema were induced on the carrageenin-induced rats, we established a novel pharmacological model on a single animal for the simultaneous evaluation of the antipyretic and anti-inflammatory effects of HQT samples. Out of the different dosages of HQT tested the dose of 7.0 g/kg body showed the highest efficacy. The PCA results showed that the 4 batches of HQT were chosen for quality assurance. No significant pharmacological differences were observed between the different batches of HQT tested, which indicated consistency in the quality of the different batches, although the component composition varied between the batches. Especially, some batches of HQT are even more effective than aspirin at some points of time. These *in vivo* results supported the findings in chemical fingerprints, suggesting the feasibility and robustness of current strategy for quality control of HQT.

The methodology of fingerprinting qualitative and quantitative analysis provides a strategy for the quality control in TCM. Additionally, an orthogonal pharmacodynamics evaluation would be a useful and efficient complementary quality control method for the herbal medicines, especially for those with unclear effective components. In order to improve the quality control for HQT, future studies should include more batches of HQT from different regions to identify and quantify more constituents and to establish different chromatographic methods. In addition, an evaluation of the pharmacodynamics at the molecular, cellular, organ and organism level are needed for a comprehensive and credible evaluation of the compounds.

5. Conclusions {#s0120}
==============

In this study, we prepared 10 batches of HQT from different sources with a standard procedure. We detected 26 common peaks in the chemical profile of HQT and ascribed by HPLC. Baicalin, wogonoside, oroxylin-A-glucoside, liquiritin, isoliquiritoside, liquiritin apioside, isoliquiritin apioside and their aglycones were identified and confirmed by LC--MS^*n*^. Ten batches of HQT were homogeneous (similarity higher than 0.990). The total contents of flavonoids in the different batches of HQT were consistent. The major components in HQT were baicalin and wogonoside. Finally, small pharmacodynamic differences between different batches of HQT samples were found, demonstrating pharmacological homogeneity of HQT. In conclusion, the results of this study indicate that the combination of chromatographic fingerprint and quantitative analysis could be readily utilized as a quality control approach for the herbal medicines of HQT.

Appendix A. Supplementary material {#s0135}
==================================
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![HPLC fingerprints of 10 batches of Huangqin Tang (similarity 0.990--1.000).](gr1){#f0005}

![HPLC chromatograms of Huangqin Tang (HQT)，Radix Scutellariae (A)，Radix Paeoniae (B)，Radix Rhizoma Glycyrrhizae (C) and Fructus Jujubae (D). 26 peaks assigned in the HQT HPLC fingerprint were unique to an individual herbal component; 22 peaks from Radix Scutellariae, 3 peaks from Radix et Rhizoma Glycyrrhizae. 1 common peak is ascribed to Radix Scutellariae and Radix et Rhizoma Glycyrrhizae, simultaneously. These peaks represented 90% of the total area, summed over the overall chromatogram from 0 to 80 min, at a threshold of 0.5%.](gr2){#f0010}

![HPLC profiles of Huangqin Tang (HQT) and mixed reference substances (MRS). 8 peaks of spectra at 276 nm (A) and 3 peaks at 370 nm (B) were confirmed. The peaks marked with 3, 10, 11, 15, 18, 22, 24, 26, 8', 9' and 22' were liquiritin, baicalin, liquiritigenin, oroxylin-A-glucoside, wogonoside, baicalein, wogonin, oroxylin-A, isoliquiritin apioside, isoliquiritoside and isoliquiritigenin. Peak 2 contains liquiritin apioside, which needs to be confirmed in future studies.](gr3){#f0015}

![Analysis of the principal components of the 10 batches of Huangqin Tang based on the input data of the principal components. Ten samples could be manually divided into 4 domains based on the score plots. HQT-S3, -S4, -S6, and -S8 were selected as the markers for the 10 batches for the following pharmacodynamic evaluation.](gr4){#f0020}

![Antipyretic and anti-inflammatory activities of Huangqin Tang (HQT-S3, -S4, -S6 and -S8) at 7.0 g/kg in carrageenan-induced fever (A) and paw edema (B) in rats (*n*=10).](gr5){#f0025}

###### 

Huangqin Tang samples used in the study and their calculated similarity values.

Table 1

  Sample No.   Batch No.   Collection site of Radix Scutellariae   Origin of Radix Scutellariae   Ratio extraction (%)   Similarity
  ------------ ----------- --------------------------------------- ------------------------------ ---------------------- ------------
  S1           20120427    Beijing Tianheng Pharmacy               Neimeng                        39.39                  1.000
  S2           20120519    Beijing Tongzhitang Pharmacy            Neimeng                        33.22                  0.998
  S3           20120512    Beijing Tongrentang Pharmacy            Neimeng                        32.56                  0.990
  S4           20120522    Beijing Hedantang Pharmacy              Neimeng                        32.67                  0.997
  S5           20120523    Beijing Jinxiang Pharmacy               Hebei                          32.11                  0.996
  S6           20120519    Beijing Yongantang Pharmacy             Hebei                          33.78                  0.999
  S7           20120427    Beijing Xingainian Pharmacy             Hebei                          38.89                  0.999
  S8           20120512    Beijing Wukesong Clinic                 Hebei                          36.00                  0.998
  S9           20120523    Beijing Jingzhitang Pharmacy            Shanxi                         33.67                  0.999
  S10          20120426    Beijing Jinglongtang Pharmacy           Shanxi                         33.56                  0.999

###### 

LC--MS identification of the common peaks in Huangqin Tang samples.

Table 2

  Peak No.   Max wave length (nm)   \[M+H\]^+^   Fragmentation ion              Identification
  ---------- ---------------------- ------------ ------------------------------ ------------------------
  2                                 550          573, 490, 317, 156             Liquirititin apioside
  3          280                    441          441, 257                       Liquiritin
  8'         370                    551          573, 515                       Isoliquiritin apioside
  9'         370                    419          419                            Isoliquiritoside
  10         285, 340               469          469, 293, 447, 271             Baicalin
  11         276                    257          257, 138                       Liquiritigenin
  15         218, 272, 310          483          483, 461, 285, 270             Oroxylin-A-glucoside
  18         220, 270               461          461, 285, 270                  Wogonoside
  22         220, 276, 322          271          271, 188, 106                  Baicalein
  22'        240, 300, 370          257          515, 432, 269, 188             Isoliquiritigenin
  24         226, 274               285          285, 270                       Wogonin
  26         274                    515          514, 432, 269, 285, 270, 203   Oroxylin-A

###### 

Calibration curve parameters, precision, repeatability, stability and recovery of the 11 compounds in Huangqin Tang.

Table 3

  Compd.                   Regression equation     Linear range (mg/L)   *R*      LLOD (mg/L)   LLOQ (mg/L)   Precision (RSD, %)   Repeatability (RSD, %)   Stability (RSD, %)   Recovery (%)/RSD (%)   
  ------------------------ ----------------------- --------------------- -------- ------------- ------------- -------------------- ------------------------ -------------------- ---------------------- -------------
  Baicalin                 *Y*=24,378*X*+495,617   11.3--2074.0          0.9998   0.13          0.519         2.34                 0.19                     1.14                 1.33                   95.59/5.03
  Wogonoside               *Y*=25,476*X*+49,692    2.3--1200.0           0.9998   0.15          0.300         2.05                 0.52                     1.36                 1.15                   93.76/4.92
  Oroxylin-A-glucoside     *Y*=30,009*X*+88,403    0.8--750.0            0.9998   0.188         0.750         2.20                 0.37                     2.3                  1.63                   91.43/4.95
  Baicalein                *Y*=52,957*X*+249,968   4.2--270.0            0.9992   0.14          0.281         2.38                 0.37                     1.07                 2.27                   90.08/3.03
  Wogonin                  *Y*=52,362*X*+74,302    1.1--72.4             0.9992   0.065         0.129         2.45                 0.18                     1.22                 2.4                    90.09/4.06
  Oroxylin-A               *Y*=36,309*X*+18,262    0.4--27.2             0.9992   0.034         0.068         2.26                 1.11                     2.33                 1.54                   90.00/4.00
  Liquiritin               *Y*=18,488*X*+12,364    4.0--129.4            1        0.135         0.539         3.46                 1.12                     1.49                 1.68                   92.74/3.83
  Isoliquiritin apioside   *Y*=28,043*X*+1106.9    0.2--6.3              0.9999   0.131         0.524         3.56                 1.54                     1.6                  2.40                   101.23/4.51
  Liquiritigenin           *Y*=25,195*X*+1247      0.2--6.4              0.9999   0.134         0.268         2.39                 0.87                     1.64                 2.50                   90.03/5.04
  Isoliquiritoside         *Y*=28,572*X*+4600      0.8--24.9             1        0.125         0.498         1.90                 1.24                     3.28                 3.70                   90.23/4.30
  Isoliquiritigenin        *Y*=57,958*X*+1310      0.1--2.9              1        0.049         0.196         3.10                 1.35                     1.22                 3.90                   99.07/2.55

LLOD, lower limit of determination; LLOQ, lower limit of quantification; *R*, correlation coefficient; RSD, relative standard deviation.

###### 

Distribution of the 11 components identified in the batches of Huangqin Tang tested (%) (*n*=3).

Table 4

  Parameter   Baicalin   Wogonoside   Oroxylin-A-glucoside   Baicalein   Wogonin   Oroxylin-A   Liquiritin   Isoliquiritin apioside   Liquiritigenin   Isoliquiritoside   Isoliquiritigenin   Total contents
  ----------- ---------- ------------ ---------------------- ----------- --------- ------------ ------------ ------------------------ ---------------- ------------------ ------------------- ----------------
  S1          10.4149    2.4179       0.8229                 0.6754      0.2215    0.0967       0.3843       0.0354                   0.0280           0.0865             0.0049              15.1884
  S2          9.8605     2.2262       0.8661                 0.4274      0.1619    0.0852       0.3195       0.0340                   0.0146           0.0769             0.0041              14.0764
  S3          5.3292     1.3881       0.5411                 0.6409      0.2280    0.1146       0.3721       0.0314                   0.0303           0.0783             0.0037              8.7577
  S4          11.1016    2.4815       1.0521                 0.3804      0.1303    0.0769       0.3951       0.0367                   0.0208           0.0885             0.0043              15.7682
  S5          7.5986     1.5775       0.5281                 0.7885      0.2510    0.1027       0.3559       0.0315                   0.0256           0.0707             0.0040              11.3341
  S6          8.1003     2.0687       0.7992                 0.7126      0.2338    0.1184       0.3426       0.0323                   0.0373           0.0736             0.0040              12.5228
  S7          10.6043    2.6353       0.7455                 0.6102      0.1381    0.0742       0.3464       0.0258                   0.0181           0.0656             0.0038              15.2673
  S8          10.094     2.3343       0.9533                 0.4114      0.1498    0.0938       0.3444       0.0361                   0.0322           0.0607             0.0035              14.5135
  S9          9.5884     2.0784       0.7473                 0.7917      0.2396    0.1134       0.3815       0.0330                   0.0246           0.0683             0.0036              14.0698
  S10         8.9704     2.044        0.7966                 0.7635      0.2409    0.1238       0.3475       0.0310                   0.0222           0.0591             0.0030              13.4020
  Min         5.3292     1.3881       0.5281                 0.3804      0.1303    0.0742       0.3195       0.0258                   0.0146           0.0591             0.0030              8.7577
  Max         11.1016    2.6353       1.0521                 0.7917      0.2510    0.1238       0.3951       0.0367                   0.0373           0.0885             0.0049              15.7682
  Mean        9.1662     2.1252       0.7852                 0.6202      0.1995    0.1000       0.3589       0.0327                   0.0240           0.0728             0.0039              13.4900
  RSD, %      18.9828    18.4393      20.6454                25.7002     24.1483   17.5545      6.5431       9.7162                   28.0428          13.6757            12.7787             15.8116

[^1]: These authors made equal contributions to this work.
